K. Cutler et al., Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus, ACT DER-VEN, 80(2), 2000, pp. 134-135
Imiquimod is a recently developed imidazoquinolin heterocyclic amine that i
s an immune response modifier. Treatment with topical 5% imiquimod cream ha
s shown promising results in the treatment of genital warts in immunocompet
ent individuals. We report here the first case of successful treatment with
topical 5% imiquimod cream of facial verrucae in an individual with human
immunodeficiency virus.